Pure Global

CITEST Multi Drug 10 Drugs Rapid Test Panel (Urine) (MOP300, MDMA500, COC300, THC50, AMP500, MET500, MTD300, BAR300, BZO300, BUP10) - Indonesia BPOM Medical Device Registration

CITEST Multi Drug 10 Drugs Rapid Test Panel (Urine) (MOP300, MDMA500, COC300, THC50, AMP500, MET500, MTD300, BAR300, BZO300, BUP10) is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 20103025326. The device is manufactured by HANGZHOU ALLTEST BIOTECH CO.,LTD from China, and is classified as Risk Class Kelas Resiko : C. The authorized representative in Indonesia is PT. MAIN MEDICAL CHAKRA.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
BPOM Registered
Risk Class Kelas Resiko : C
CITEST Multi Drug 10 Drugs Rapid Test Panel (Urine) (MOP300, MDMA500, COC300, THC50, AMP500, MET500, MTD300, BAR300, BZO300, BUP10)
Analysis ID: AKL 20103025326

Risk Classification

Kelas Resiko : C

Product Class

Kelas : 2

Country of Origin

China

Authorized Representative

PT. MAIN MEDICAL CHAKRA

AR Address

FORESTA BUSINESS LOFT 6 No. 10, Jl. Raya Boulevard Utara BSD City, Desa/Kelurahan Lengkong Kulon

Registration Date

May 31, 2024

Expiry Date

Mar 25, 2027

Product Type

Clinical Toxicology Test System

Multi parameter clinical toxicology test system

Invitro Diagnostics

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing